HLA-DR Antibody (HL-39) [DyLight 680] Summary
Raji Burkitts lymphoma cell line
The antibody HL-39 recognizes common epitope on human HLA-DR which is dependent on the association of alpha and beta chains. Recognized epitope is conserved after fixation with glutaraldehyde and formaldehyde. DR is the isotype of human MHC Class II molecules expressed on antigen-presenting cells (APC; dendritic cells, B lymphocytes, monocytes, macrophages).
IgG3
Monoclonal
Mouse
HLA-DRA
Protein A purified
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
Applications/Dilutions
- Flow Cytometry
Optimal dilution of this antibody should be experimentally determined.
Packaging, Storage & Formulations
Store at 4C in the dark.
50mM Sodium Borate
0.05% Sodium Azide
Protein A purified
Notes
Dylight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
Alternate Names for HLA-DR Antibody (HL-39) [DyLight 680]
- FLJ51114
- histocompatibility antigen HLA-DR alpha
- HLA class II histocompatibility antigen, DR alpha chain
- HLADR
- HLA-DR
- HLA-DRA
- HLA-DRA1
- major histocompatibility complex, class II, DR alpha
- MHC cell surface glycoprotein
- MHC class II antigen DRA
- MHC Class II DR
- MLRW
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.